Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | Yes |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Hanall Biopharma Co., Ltd. |
| Oscotec Inc. |
| WooGene B&G Co., Ltd |
| Komipharm International Co., Ltd. |
| ADBiotech Co., Ltd. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| A009420 | A039200 | A018620 | A041960 | A179530 | A140410 | |||
| Return On Equity | ||||||||
| Latest Twelve Months | -1% | 0% | -17% | 21% | -49% | -45% | ||
| Fiscal Year - 1 | 2% | -22% | -3% | -7% | -19% | -29% | ||
| Fiscal Year - 2 | 0% | -32% | 3% | -10% | 25% | -82% | ||
| Fiscal Year - 3 | 5% | -64% | -7% | -6% | -37% | -23% | ||
| Fiscal Year - 4 | 12% | -8% | -11% | -4% | -79% | -28% | ||
| Fiscal Year - 5 | 15% | -46% | -1% | -26% | NA | -47% | ||
| Average | 6% | -29% | -6% | -5% | -32% | -42% | ||
| Median | 4% | -27% | -5% | -7% | -37% | -37% | ||
| Benchmarks | Ticker | |||||||
| Hanall Biopharma Co., Ltd. | KOSE:A009420 | |||||||
| Oscotec Inc. | KOSDAQ:A039200 | |||||||
| WooGene B&G Co., Ltd | KOSDAQ:A018620 | |||||||
| Komipharm International Co., Ltd. | KOSDAQ:A041960 | |||||||
| ADBiotech Co., Ltd. | KOSDAQ:A179530 | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | A009420 | A039200 | A018620 | A041960 | A179530 | A140410 | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Mar-25 | Mar-25 | Mar-25 | Mar-25 | Mar-25 | Mar-25 | ||
| Revenues | ||||||||
| Latest Twelve Months | 141,000 | 34,882 | 53,933 | 60,288 | 11,660 | 8,407 | ||
| Fiscal Year | 138,944 | 34,008 | 55,680 | 58,779 | 11,136 | 8,612 | ||
| Fiscal Year - 1 | 134,910 | 4,951 | 57,919 | 42,647 | 10,472 | 31,721 | ||
| Fiscal Year - 2 | 109,995 | 5,062 | 43,703 | 39,801 | 10,632 | 30,726 | ||
| Fiscal Year - 3 | 101,594 | 3,903 | 39,347 | 35,847 | 11,840 | 26,654 | ||
| Fiscal Year - 4 | 88,602 | 43,471 | 39,524 | 37,160 | 9,815 | 28,634 | ||
| Fiscal Year - 5 | 108,452 | 4,369 | 29,656 | 35,490 | NA | 17,920 | ||
| Net Income | ||||||||
| Latest Twelve Months | (1,689) | 385 | (5,071) | 12,392 | (4,075) | (22,858) | ||
| Fiscal Year | (1,805) | 877 | (5,221) | 13,113 | (7,952) | (19,477) | ||
| Fiscal Year - 1 | 3,509 | (24,280) | (1,184) | (3,979) | (2,863) | (12,728) | ||
| Fiscal Year - 2 | 251 | (24,430) | 850 | (6,514) | 2,696 | (36,298) | ||
| Fiscal Year - 3 | 8,896 | (26,263) | (2,258) | (4,459) | (2,664) | (13,603) | ||
| Fiscal Year - 4 | 19,765 | (4,357) | (3,030) | (2,816) | (7,345) | (13,873) | ||
| Fiscal Year - 5 | 19,174 | (22,601) | (333) | (21,363) | NA | (23,301) | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 221,516 | 125,726 | 124,234 | 115,641 | 22,896 | 87,719 | ||
| Latest Fiscal Quarter | 195,719 | 163,290 | 109,645 | 122,770 | 25,329 | 70,839 | ||
| Fiscal Year | 212,881 | 170,778 | 112,870 | 122,767 | 23,074 | 73,998 | ||
| Fiscal Year - 1 | 239,747 | 132,578 | 121,583 | 118,598 | 28,093 | 92,149 | ||
| Fiscal Year - 2 | 213,451 | 143,736 | 91,522 | 111,751 | 31,018 | 54,022 | ||
| Fiscal Year - 3 | 198,478 | 48,967 | 76,508 | 115,262 | 20,959 | 83,935 | ||
| Fiscal Year - 4 | 220,132 | 76,388 | 77,561 | 121,913 | 18,840 | 75,625 | ||
| Fiscal Year - 5 | 191,383 | 72,393 | 85,132 | 125,644 | NA | 58,874 | ||
| Fiscal Year - 6 | 162,304 | 70,259 | 60,049 | 139,904 | NA | 75,059 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 178,205 | 93,010 | 33,713 | 56,919 | 8,996 | 57,747 | ||
| Latest Fiscal Quarter | 159,305 | 121,785 | 27,358 | 62,389 | 7,486 | 43,259 | ||
| Fiscal Year | 168,351 | 127,756 | 27,793 | 62,280 | 4,837 | 46,063 | ||
| Fiscal Year - 1 | 186,218 | 98,918 | 33,524 | 56,338 | 13,393 | 61,444 | ||
| Fiscal Year - 2 | 168,256 | 122,508 | 35,317 | 60,631 | 16,185 | 26,240 | ||
| Fiscal Year - 3 | 163,492 | 28,828 | 31,144 | 66,460 | 5,106 | 62,793 | ||
| Fiscal Year - 4 | 181,273 | 53,050 | 29,845 | 76,275 | 9,327 | 56,810 | ||
| Fiscal Year - 5 | 140,417 | 51,288 | 27,266 | 73,276 | NA | 42,830 | ||
| Fiscal Year - 6 | 116,918 | 46,290 | 26,513 | 93,389 | NA | 57,319 | ||